The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Unitedhealth Group (NYSE:UNH), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD).
The investment seeks long-term capital growth.
To pursue its goal, the fund primarily invests in equity securities issued by companies in the health care sector. The health care sector may include, for example, pharmaceutical and biotechnology companies, health care facilities operations, medical product manufacturers and suppliers, medical providers and medical services firms. It is the fund's policy that under normal circumstances it will invest at least 80% of its net assets in these securities; typically, the actual percentage will be higher. The fund will concentrate its investments in securities of companies in the health care sector.
The average market capitalization across the Schwab Health Care MF is 194.58B. The market cap for tickers in the group ranges from 90.24B to 561.54B. LLY holds the highest valuation in this group at 561.54B. The lowest valued company is VRTX at 90.24B.
The average weekly volume growth across all stocks in the Schwab Health Care MF was -5%. For the same stocks of the MF, the average monthly volume growth was -28% and the average quarterly volume growth was -0%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 34
P/E Growth Rating: 50
Price Growth Rating: 51
SMR Rating: 46
Profit Risk Rating: 37
Seasonality Score: 27 (-100 ... +100)